Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FYSFX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,345
Award facts
- Contract value 100% obligated
- $25,344.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $25.3K to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that establishes a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through the DLA Medical Supply Chain, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic areas. As a major healthcare solutions provider, the company has demonstrated consistent capability to meet federal procurement requirements through competitive award processes. This specific delivery order for Enbrel, a TNF inhibitor biologic used in rheumatoid arthritis and other autoimmune conditions, exemplifies the company's role in supporting the Defense Health Agency and broader military healthcare programs with specialty pharmaceuticals and auto-injector delivery systems.
Quick answers
Who was awarded contract SPE2DB25FYSFX?
SPE2DB25FYSFX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FYSFX worth?
The government has obligated $25,345 on SPE2DB25FYSFX.
Is contract SPE2DB25FYSFX an order under another contract?
Yes. SPE2DB25FYSFX is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYSFX competed?
The extent of competition for SPE2DB25FYSFX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award